Viewing Study NCT02652494


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-02-25 @ 8:51 PM
Study NCT ID: NCT02652494
Status: COMPLETED
Last Update Posted: 2024-05-13
First Post: 2016-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study of Apremilast in Patients With Psoriasis in The Netherlands
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None Observational View
None Apremilast View
None APRIL View
None Non-Interventional View
None The Netherlands View